BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7956939)

  • 1. Recombinant thyrotropin receptor and the induction of autoimmune thyroid disease in BALB/c mice: a new animal model.
    Costagliola S; Many MC; Stalmans-Falys M; Tonacchera M; Vassart G; Ludgate M
    Endocrinology; 1994 Nov; 135(5):2150-9. PubMed ID: 7956939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of thyroiditis, with syngeneic spleen cells sensitized with the human thyrotropin receptor, to naive BALB/c and NOD mice.
    Costagliola S; Many MC; Stalmans-Falys M; Vassart G; Ludgate M
    Endocrinology; 1996 Nov; 137(11):4637-43. PubMed ID: 8895327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The autoimmune response induced by immunising female mice with recombinant human thyrotropin receptor varies with the genetic background.
    Costagliola S; Many MC; Stalmans-Falys M; Vassart G; Ludgate M
    Mol Cell Endocrinol; 1995 Dec; 115(2):199-206. PubMed ID: 8824895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of thyrotropin receptor (TSH-R) autoantibodies and thyroiditis in mice immunised with the recombinant TSH-R.
    Costagliola S; Alcalde L; Tonacchera M; Ruf J; Vassart G; Ludgate M
    Biochem Biophys Res Commun; 1994 Mar; 199(2):1027-34. PubMed ID: 8135775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an animal model of autoimmune thyroid eye disease.
    Many MC; Costagliola S; Detrait M; Denef F; Vassart G; Ludgate MC
    J Immunol; 1999 Apr; 162(8):4966-74. PubMed ID: 10202044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG; Ho SC; Minich WB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease.
    Diana T; Krause J; Olivo PD; König J; Kanitz M; Decallonne B; Kahaly GJ
    Clin Exp Immunol; 2017 Sep; 189(3):304-309. PubMed ID: 28439882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor.
    Costagliola S; Rodien P; Many MC; Ludgate M; Vassart G
    J Immunol; 1998 Feb; 160(3):1458-65. PubMed ID: 9570567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor.
    Watanabe Y; Tahara K; Hirai A; Tada H; Kohn LD; Amino N
    Thyroid; 1997 Feb; 7(1):13-9. PubMed ID: 9086564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies.
    Akamizu T; Kohn LD; Hiratani H; Saijo M; Tahara K; Nakao K
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2116-21. PubMed ID: 10852437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.
    Baker G; Mazziotti G; von Ruhland C; Ludgate M
    Endocrinology; 2005 Feb; 146(2):835-44. PubMed ID: 15542454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.
    Hovens GC; Buiting AM; Karperien M; Ballieux BE; van der Pluijm G; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
    Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
    Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific effects of radioiodine treatment on TSAb and TBAb levels in patients with Graves' disease.
    Michelangeli VP; Poon C; Topliss DJ; Colman PG
    Thyroid; 1995 Jun; 5(3):171-6. PubMed ID: 7580264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the levels of TSH-binding inhibitor immunoglobulins in goitrous and agoitrous autoimmune thyroiditis after twelve months of L-thyroxine therapy.
    Khoo DH; Eng PH; Ho SC; Fok AC
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):73-9. PubMed ID: 10468968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of thyroid blocking antibody (TBAb) on the thyroid stimulatory effect of human chorionic gonadotropin (HCG) and equine chorionic gonadotropin (ECG).
    Ochi Y; Hamazu M; Kajita Y; Hachiya T; Hamaoki M
    Endocr J; 2010; 57(4):311-5. PubMed ID: 20351465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly variable sensitivity of five binding and two bio-assays for TSH-receptor antibodies.
    Diana T; Wüster C; Kanitz M; Kahaly GJ
    J Endocrinol Invest; 2016 Oct; 39(10):1159-65. PubMed ID: 27197966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins.
    Takasu N; Yamada T; Katakura M; Yamauchi K; Shimizu Y; Ishizuki Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):239-45. PubMed ID: 2878935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting activities of thyrotropin receptor antibodies in experimental models of Graves' disease induced by injection of transfected fibroblasts or deoxyribonucleic acid vaccination.
    Rao PV; Watson PF; Weetman AP; Carayanniotis G; Banga JP
    Endocrinology; 2003 Jan; 144(1):260-6. PubMed ID: 12488353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.